Short-course tocilizumab may up hep B reactivation in RA
(HealthDay)—For patients with rheumatoid arthritis (RA), one to three doses of tocilizumab may increase the risk of hepatitis B virus (HBV) reactivation, according to a study published online Feb. 3 in the International ...
Feb 13, 2017
0
1